Published in Gene Therapy Weekly, April 12th, 1999
M. Praus and colleagues from the Katholieke University Leuven, Belgium, employed recombinant adenoviral vectors to express u-PA, t-PA, PAI-1 and PAI-2 to correlate the expression of components of the fibrinolytic system with the invasiveness of HT 1080 tumor cells ("Reduction of Tumor Cell Migration and Metastasis by Adenoviral Gene Transfer of Plasminogen Activator Inhibitors," Gene Therapy, February 1999;6(2):227-236).
"Migration through Transwell inserts in vitro in the presence of plasminogen was increased up to 22 percent by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.